Subject(s)

Coronavirus Infections/drug therapy , Cytokines/immunology , Pneumonia, Viral/drug therapy , Ritonavir/administration & dosage , Adolescent , Adult , Betacoronavirus/pathogenicity , COVID-19 , Chemical and Drug Induced Liver Injury/complications , Chemical and Drug Induced Liver Injury/physiopathology , Chemical and Drug Induced Liver Injury/virology , Child , Coronavirus Infections/complications , Coronavirus Infections/immunology , Coronavirus Infections/virology , Cytokines/classification , Female , Humans , Inflammation/complications , Inflammation/physiopathology , Inflammation/virology , Male , Middle Aged , Pandemics , Pneumonia, Viral/complications , Pneumonia, Viral/immunology , Pneumonia, Viral/virology , Ritonavir/adverse effects , SARS-CoV-2 , T-Lymphocyte Subsets/drug effects , T-Lymphocyte Subsets/pathology , Young Adult , COVID-19 Drug Treatment